# Study of Recombinant Human Thrombin for Bleeding During Autologous Skin Grafting

> **NCT00371215** · PHASE2 · COMPLETED · sponsor: **ZymoGenetics** · enrollment: 72 (actual)

## Conditions studied

- Surgical Hemostasis

## Interventions

- **BIOLOGICAL:** rThrombin

## Key facts

- **NCT ID:** NCT00371215
- **Lead sponsor:** ZymoGenetics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2009-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00371215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00371215, "Study of Recombinant Human Thrombin for Bleeding During Autologous Skin Grafting". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00371215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*